Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. VMD
VMD logo

VMD Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
9.775
Open
9.460
VWAP
9.65
Vol
256.73K
Mkt Cap
373.29M
Low
9.460
Amount
2.48M
EV/EBITDA(TTM)
7.64
Total Shares
38.48M
EV
374.15M
EV/OCF(TTM)
5.61
P/S(TTM)
1.38
Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services.
Show More

Events Timeline

(ET)
2026-03-04
16:50:00
Viemed Healthcare Authorizes Share Repurchase Program Through March 2027
select
2025-07-02 (ET)
2025-07-02
08:43:56
Viemed Healthcare completes acquisition of Lehan's Medical Equipment
select
2025-06-09 (ET)
2025-06-09
08:18:09
Viemed Healthcare board authorizes share repurchase program up to 5%
select
2025-05-06 (ET)
2025-05-06
08:32:47
Viemed entered into definitive agreement to acquire Lehan's Medical Equipment
select
2025-03-10 (ET)
2025-03-10
17:02:06
Viemed Healthcare sees FY25 revenue $254M-$265M, consensus $251.43M
select
2025-03-10
17:01:21
Viemed Healthcare reports Q4 EPS 10c vs 9c last year
select

News

seekingalpha
9.5
05-05seekingalpha
PinnedViemed Healthcare to Announce Q1 Earnings on May 6
  • Earnings Announcement: Viemed Healthcare is set to release its Q1 earnings on May 6 before market open, with a consensus EPS estimate of $0.09, reflecting a significant 50% year-over-year increase, indicating strong profitability improvements.
  • Revenue Expectations: Analysts forecast that VMD's Q1 revenue will reach $74.4 million, representing a 25.9% year-over-year growth, which will further solidify the company's market position in the healthcare sector.
  • Performance Beat Record: Over the past year, Viemed Healthcare has beaten EPS and revenue estimates 75% of the time, demonstrating the company's financial stability and effective management execution.
  • Share Repurchase Program: Viemed Healthcare has authorized a share repurchase program through March 2027, which not only reflects the company's confidence in its stock value but also has the potential to provide additional returns to shareholders.
seekingalpha
9.5
05:11 AMseekingalpha
Viemed Healthcare Q1 Earnings Beat Expectations with Strong Revenue Growth
  • Significant Revenue Growth: Viemed Healthcare reported Q1 revenue of $75.41 million, reflecting a 27.5% year-over-year increase, exceeding market expectations by $1.01 million, indicating strong demand and an increase in market share in the medical equipment sector.
  • Adjusted EBITDA Increase: The adjusted EBITDA for the quarter ended March 31, 2026, totaled $14.3 million, representing a 12% increase compared to the same period last year, showcasing ongoing improvements in operational efficiency and cost control, which enhance profitability.
  • Strong Cash Flow Performance: The net cash provided by operating activities for the quarter was $8.1 million, with a total of $57.1 million over the trailing twelve months, demonstrating robust cash management that supports future investments and expansion.
  • Updated 2026 Guidance: The company has revised its 2026 revenue guidance to a range of $312 million to $320 million, up from the previous range, reflecting positive trends in new patient starts and an optimized revenue mix, which further boosts market confidence.
Newsfilter
9.5
04-21Newsfilter
Viemed to Host Q1 2026 Earnings Call on May 6
  • Earnings Call Announcement: Viemed Healthcare will host its Q1 2026 earnings conference call on May 6, 2026, at 11:00 a.m. EDT, aimed at providing investors and analysts with updates on financial performance and business developments.
  • Participation Details: Interested parties can join the call by dialing 877-407-6176 (US Toll-Free) or +1 201-689-8451 (International), ensuring global investors have convenient access to company information.
  • Live Audio Webcast: The call will be available via a live audio webcast, accessible through the provided link, which enhances transparency and broadens the reach of information dissemination, thereby strengthening investor relations.
  • Replay Availability: Following the live call, a replay will be accessible in the Investor Relations section of the company's website, ensuring that investors who cannot participate in real-time can still obtain relevant information, thus improving communication efficiency between the company and its investors.
NASDAQ.COM
2.0
03-05NASDAQ.COM
Viemed (VMD) Q4 2025 Earnings Call Transcript
seekingalpha
9.5
03-05seekingalpha
Viemed Healthcare Q4 Earnings Beat Expectations
  • Earnings Highlights: Viemed Healthcare reported Q4 GAAP EPS of $0.14, beating expectations by $0.05, although revenue of $76.2 million, up 25.5% year-over-year, missed by $1.15 million, indicating challenges in balancing growth and profitability.
  • Adjusted EBITDA Growth: For the year ending December 31, 2025, adjusted EBITDA reached $18.2 million, with a record $61.4 million for the full year, demonstrating the company's ability to maintain strong profitability amid ongoing growth, which bolsters investor confidence.
  • Significant Free Cash Flow Increase: The free cash flow for 2025 totaled $28.1 million, a substantial increase from $11.6 million in 2024, reflecting improvements in operational efficiency and cash management, which will support future investments and shareholder returns.
  • 2026 Financial Guidance: The company expects net revenue for 2026 to be in the range of $310 million to $320 million, below the market consensus of $328.73 million, with adjusted EBITDA projected between $65 million and $69 million, indicating a cautiously optimistic outlook for future growth.
seekingalpha
8.0
03-04seekingalpha
Viemed Healthcare Authorizes Share Repurchase Program
  • Repurchase Program Initiation: Viemed Healthcare's board approved a share repurchase program on Wednesday, allowing for the buyback of up to 1,930,131 common shares, which represents approximately 5% of its issued shares as of March 4, 2026.
  • Flexible Repurchase Methods: The company plans to execute repurchases through open market or block purchases, adhering to applicable securities laws, including Rule 10b-18 under the Securities Exchange Act of 1934, ensuring compliance and transparency.
  • Daily Purchase Limitations: Daily repurchases will be capped at 25% of the average daily trading volume over the preceding four weeks, which aims to mitigate market volatility and protect shareholder interests during the buyback period.
  • Share Cancellation Policy: Shares repurchased under this program will be canceled, and while the company has indicated that there is no assurance regarding the number of shares to be repurchased, the ability to discontinue purchases at any time reflects a cautious and flexible approach to capital management.

Valuation Metrics

The current forward P/E ratio for Viemed Healthcare Inc (VMD.O) is 21.55, compared to its 5-year average forward P/E of 24.43. For a more detailed relative valuation and DCF analysis to assess Viemed Healthcare Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
24.43
Current PE
21.55
Overvalued PE
31.56
Undervalued PE
17.30

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
6.22
Current EV/EBITDA
5.21
Overvalued EV/EBITDA
7.82
Undervalued EV/EBITDA
4.61

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.43
Current PS
1.01
Overvalued PS
1.86
Undervalued PS
1.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

best stock for swing traders tomorrow
Intellectia · 75 candidates
Price: $5.00 - $100.00Rsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceCrossAboveMA20One Day Rise Prob: >= 60Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
DNLI logo
DNLI
Denali Therapeutics Inc
3.15B
MITK logo
MITK
Mitek Systems Inc
647.57M
SXC logo
SXC
SunCoke Energy Inc
552.33M
RDWR logo
RDWR
Radware Ltd
1.10B
DHT logo
DHT
DHT Holdings Inc
2.91B
PHVS logo
PHVS
Pharvaris NV
1.87B
best swing trades at or near $10
Intellectia · 27 candidates
Price: $8.00 - $12.00Rsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Month Price Change Pct: $5.00 - $25.00One Week Predict Return: 0.0% - 100.0%Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
ANGO logo
ANGO
AngioDynamics Inc
462.46M
HLX logo
HLX
Helix Energy Solutions Group Inc
1.31B
HTLD logo
HTLD
Heartland Express Inc
910.75M
VMD logo
VMD
Viemed Healthcare Inc
313.27M
LNKB logo
LNKB
LINKBANCORP Inc
346.49M
SENS logo
SENS
Senseonics Holdings Inc
333.41M
what trades can I do within my budget
Intellectia · 43 candidates
Region: USPrice: $5.00 - $50.00Rsi Category: moderate, overboughtPrice Change Pct: $2.00 - $10.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SIRI logo
SIRI
Sirius XM Holdings Inc
7.69B
BYRN logo
BYRN
Byrna Technologies Inc
281.11M
RMR logo
RMR
RMR Group Inc
533.45M
ASX logo
ASX
ASE Technology Holding Co Ltd
43.15B
ORN logo
ORN
Orion Group Holdings Inc
545.05M
MCFT logo
MCFT
Mastercraft Boat Holdings Inc
395.64M

Whales Holding VMD

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Viemed Healthcare Inc (VMD) stock price today?

The current price of VMD is 9.7 USD — it has increased 2.32

What is Viemed Healthcare Inc (VMD)'s business?

Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services.

What is the price predicton of VMD Stock?

Wall Street analysts forecast VMD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for VMD is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Viemed Healthcare Inc (VMD)'s revenue for the last quarter?

Viemed Healthcare Inc revenue for the last quarter amounts to 76.18M USD, increased 25.51

What is Viemed Healthcare Inc (VMD)'s earnings per share (EPS) for the last quarter?

Viemed Healthcare Inc. EPS for the last quarter amounts to 0.14 USD, increased 40.00

How many employees does Viemed Healthcare Inc (VMD). have?

Viemed Healthcare Inc (VMD) has 3000 emplpoyees as of May 06 2026.

What is Viemed Healthcare Inc (VMD) market cap?

Today VMD has the market capitalization of 373.29M USD.